Bailard’s Allergan plc AGN Stock Holding History

Bailard’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-867	Closed	-$211K	–	313
2017 Q2	$211K	Hold	867	–	–	0.02%	268
2017 Q1	$207K	Buy	+867	New	+$202K	0.02%	283

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Bailard's AGN Position: Q3 2017 in Review

Bailard sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 867 shares — an estimated $211K sold.

Bailard first reported a position in AGN in Q1 2017 and held it in 2 quarters. The position peaked at $211K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Bailard reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Bailard sold 867 Allergan plc shares in Q3 2017, an estimated $211K.
Bailard first reported a position in Allergan plc in Q1 2017 and held it in 2 quarters.
Bailard's Allergan plc position peaked at $211K in Q2 2017.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Bailard's 13F filing for Q3 2017, filed 11 Oct 2017.